Release Date: 01/08/13 08:22 Summary: LNC Quarterly Activities & Cashflow Report Price Sensitive: Yes Download Document 862.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%